Last reviewed · How we verify
Gabapentin 300mg
At a glance
| Generic name | Gabapentin 300mg |
|---|---|
| Also known as | Neurontin, Novo-gabapentin, NEUROTIN, placebo tablet |
| Sponsor | British Columbia Cancer Agency |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Enhanced Recovery After Surgery (ERAS) in Live Donor Kidney Transplant Recipients (PHASE4)
- Pregabalin vs. Gabapentin on Reducing Opioid Usage (PHASE4)
- Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial (PHASE1)
- Gabapentin and Neural Mobilization Pain Reduction Effect Compared to Only Gabapentine (PHASE4)
- Pain Reduction Caused by the Combined Treatment of Physiotherapy, Oral Gabapentin and Oral Ibuprofen Arginine. (PHASE4)
- Gabapentin to Reduce Alcohol and Improve Viral Load Suppression (PHASE2)
- Impact of Preoperative Opioid-free Multimodal Analgesia on Time to Trial of Void in Ambulatory Urogynecologic Surgeries (PHASE4)
- Assessment of Safety and Efficacy of Gabapentin After Surface Ablation, a Case Control Experimental Study (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |